Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 515 of 1,261
  1. US 10214732

    Lysin agent and method of use for diagnostic testing

    The United States of America, as represented by the Secretary of Homeland Security · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted
  2. US 10214529

    Small molecules for the treatment of primary cancer and cancer metastasis

    The Board of Regents of the University of Texas System · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted
  3. US 10214553

    Solid state forms of sofosbuvir

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted
  4. US 10213395

    Toxic aldehyde related diseases and treatment

    Aldeyra Therapeutics, Inc. · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted
  5. US 10214721

    Method for making culture medium

    HON HAI PRECISION INDUSTRY CO., LTD. · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted
  6. US 10212923

    Humanized dipeptidyl-peptidase IV (DPP4) animals

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted
  7. US 10213388

    Abuse resistant oral dosage forms

    Elite Laboratories, Inc. · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted
  8. US 10214536

    Amlexanox analogs

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted
  9. US 10214581

    Compositions and methods for treating and preventing Staphylococcus aureus infections

    XBIOTECH INC. · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted
  10. US 10214531

    Substituted amino triazoles, and methods using same

    Institute for Drug Discovery, LLC · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted
  11. US 10214509

    Amino-substituted heterocyclic derivatives as sodium channel inhibitors

    Almirall, S.A. · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted
  12. US 10214498

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted
  13. US 10214508

    Nitrogen-containing heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted
  14. US 10213510

    Long-acting polymeric delivery systems

    Heron Therapeutics, Inc. · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted
  15. US 10213508

    Etanercept formulations stabilized with xylitol

    Coherus BioSciences, Inc. · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted
  16. US 2019055264

    Macrocyclic MCL-1 inhibitors and methods of use

    ABBVIE INC [US] · Granted Feb 21, 2019 · Expires Feb 16, 2039

    granted
  17. EP 3442949

    KONTRASTMITTEL

    BRACCO IMAGING SPA [IT] · Granted Feb 20, 2019 · Expires Feb 15, 2039

    granted
  18. US 10207003

    Liquid pentablock co-polymer formulations for sustained delivery of therapeutics

    inovion, Inc. · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted
  19. US 10208111

    Alpha-synuclein antibodies and uses thereof

    UNITED ARAB EMIRATES UNIVERSITY · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted
  20. US 10208059

    Heterocyclic modulators of HIF activity for treatment of disease

    The Board of Regents of the University of Texas System · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted
  21. US 10207993

    Compounds as anti-tubercular agents

    DRUG DISCOVERY RESEARCH CENTRE · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted
  22. US 10206933

    Non-hormonal steroid modulators of NF-kB for treatment of disease

    ReveraGen BioPharma, Inc. · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted
  23. US 10206924

    Small molecule inhibitors of EGFR and PI3K

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted
  24. US 10206897

    Creatine ester anti-inflammatory compounds and formulations

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.